» Articles » PMID: 26527320

Tumorsphere As an Effective in Vitro Platform for Screening Anti-cancer Stem Cell Drugs

Overview
Journal Oncotarget
Specialty Oncology
Date 2015 Nov 4
PMID 26527320
Citations 98
Authors
Affiliations
Soon will be listed here.
Abstract

Cancer stem cells (CSCs) are a sub-population of cells within cancer tissues with tumor initiation, drug resistance and metastasis properties. CSCs also have been considered as the main cause of cancer recurrence. Targeting CSCs have been suggested as the key for successful treatment against cancer. Tumorsphere cultivation is based on culturing cancer cells onto ultralow attachment surface in serum-free media under the supplementation with growth factors such as epidermal growth factor and basic fibroblast growth factor. Tumorsphere cultivation is widely used to analyze the self-renewal capability of CSCs and to enrich these cells from bulk cancer cells. This method also provides a reliable platform for screening potential anti-CSC agents. The in vitro anti-proliferation activity of potential agents selected from tumorsphere assay is more translatable into in vivo anti-tumorigenic activity compared with general monolayer culture. Tumorsphere assay can also measure the outcome of clinical trials for potential anti-cancer agents. In addition, tumorsphere assay may be a promising strategy in the innovation of future cancer therapeutica and may help in the screening of anti-cancer small-molecule chemicals.

Citing Articles

Current preclinical models of brain metastasis.

Drouin Z, Levesque F, Mouzakitis K, Labrie M Clin Exp Metastasis. 2024; 42(1):5.

PMID: 39694975 DOI: 10.1007/s10585-024-10318-x.


Oxidative Phosphorylation as a Predictive Biomarker of Oxaliplatin Response in Colorectal Cancer.

Martinez-Bernabe T, Pons D, Oliver J, Sastre-Serra J Biomolecules. 2024; 14(11).

PMID: 39595536 PMC: 11591675. DOI: 10.3390/biom14111359.


Self-assembled aldehyde dehydrogenase-activatable nano-prodrug for cancer stem cell-enriched tumor detection and treatment.

Li B, Tian J, Zhang F, Wu C, Li Z, Wang D Nat Commun. 2024; 15(1):9417.

PMID: 39482286 PMC: 11528051. DOI: 10.1038/s41467-024-53771-8.


Suppressing Expression of SERPINE1/PAI1 Through Activation of GPER1 Reduces Progression of Vulvar Carcinoma.

Doelker T, Gallwas J, Grundker C Cancer Genomics Proteomics. 2024; 21(6):566-579.

PMID: 39467628 PMC: 11534035. DOI: 10.21873/cgp.20473.


Exploring the Use of Intracellular Chelation and Non-Iron Metals to Program Ferroptosis for Anticancer Application.

Claudio-Ares O, Luciano-Rodriguez J, Del Valle-Gonzalez Y, Schiavone-Chamorro S, Pastor A, Rivera-Reyes J Inorganics (Basel). 2024; 12(1).

PMID: 39380574 PMC: 11460773. DOI: 10.3390/inorganics12010026.


References
1.
Zhan H, Xu J, Wu D, Zhang T, Hu S . Pancreatic cancer stem cells: new insight into a stubborn disease. Cancer Lett. 2014; 357(2):429-37. DOI: 10.1016/j.canlet.2014.12.004. View

2.
Zhou J, Zhang H, Gu P, Margolick J, Yin D, Zhang Y . Cancer stem/progenitor cell active compound 8-quinolinol in combination with paclitaxel achieves an improved cure of breast cancer in the mouse model. Breast Cancer Res Treat. 2008; 115(2):269-77. PMC: 3320107. DOI: 10.1007/s10549-008-0072-8. View

3.
Hayashi T, Ding Q, Kuwahata T, Maeda K, Miyazaki Y, Matsubara S . Interferon-alpha modulates the chemosensitivity of CD133-expressing pancreatic cancer cells to gemcitabine. Cancer Sci. 2012; 103(5):889-96. PMC: 7659312. DOI: 10.1111/j.1349-7006.2012.02235.x. View

4.
Liao J, Qian F, Tchabo N, Mhawech-Fauceglia P, Beck A, Qian Z . Ovarian cancer spheroid cells with stem cell-like properties contribute to tumor generation, metastasis and chemotherapy resistance through hypoxia-resistant metabolism. PLoS One. 2014; 9(1):e84941. PMC: 3883678. DOI: 10.1371/journal.pone.0084941. View

5.
Chang W, Kuan Y, Chen M, Lin S, Lee C . Tracking of mouse breast cancer stem-like cells with Salmonella. Exp Biol Med (Maywood). 2012; 237(10):1189-96. DOI: 10.1258/ebm.2012.012063. View